XASXHPP
Market cap3mUSD
Aug 25, Last price
0.04AUD
Name
Health and Plant Protein Group Ltd
Chart & Performance
Profile
Health and Plant Protein Group Limited engages in the processing, production, and marketing of macadamia products to wholesale and retail customers in North America. It offers its products under the Royal Hawaiian Orchards and MacFarms brands. The company was formerly known as Buderim Group Limited and changed its name to Health and Plant Protein Group Limited in December 2020. Health and Plant Protein Group Limited was founded in 1941 and is headquartered in Milton, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 42,250 16.62% | |||||||||
Cost of revenue | 1,090 | 4,670 | 42,360 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (1,090) | (4,670) | (110) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (79) | |||||||||
Tax Rate | ||||||||||
NOPAT | (1,090) | (4,670) | (31) | |||||||
Net income | (801) -95.24% | (16,829) -2,630.68% | 665 -106.58% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (393) | |||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,624 | |||||||||
Long-term debt | 20,792 | |||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 367 | |||||||||
Net debt | (1,288) | (3,745) | (9,979) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (1,345) | (8,730) | 1,398 | |||||||
CAPEX | (822) | |||||||||
Cash from investing activities | (592) | 16,711 | (948) | |||||||
Cash from financing activities | (513) | (8,842) | 297 | |||||||
FCF | (5,953) | 42,179 | (9,035) | |||||||
Balance | ||||||||||
Cash | 1,288 | 3,745 | 3,470 | |||||||
Long term investments | 28,925 | |||||||||
Excess cash | 1,288 | 3,745 | 30,282 | |||||||
Stockholders' equity | 6,151 | 7,287 | 25,043 | |||||||
Invested Capital | 4,863 | 3,542 | 21,543 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 120,695 | 122,831 | 122,831 | |||||||
Price | 0.05 -31.43% | 0.07 -74.07% | ||||||||
Market cap | 5,896 -31.43% | 8,598 -70.25% | ||||||||
EV | 2,151 | (1,381) | ||||||||
EBITDA | (1,090) | (4,539) | 99 | |||||||
EV/EBITDA | ||||||||||
Interest | 3,494 | 1,461 | ||||||||
Interest/NOPBT |